Cargando…
Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification
Accumulating evidence suggests that prostatic cancers represent a group of histologically and molecularly heterogeneous diseases with variable clinical courses. In accordance with the increased knowledge of their clinicopathologies and genetics, the World Health Organization (WHO) classification of...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865702/ https://www.ncbi.nlm.nih.gov/pubmed/29581876 http://dx.doi.org/10.18632/oncotarget.24515 |